CD95 ligand (CD95L) in normal human lymphoid tissues: A subset of plasma cells are prominent producers of CD95L

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 193-201

  Sträter, Jörn ^a   Mariani, Sara M ^a   Walczak, Henning ^a   Rücker, Frank G ^a   Leithäuser, Frank ^a   Krammer, Peter H ^a   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LAMINA PROPRIA; LYMPH NODE; LYMPHOID TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SPLEEN; THYMUS;

EID: 0032950651     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65265-0     Document Type: Article

References (36)

1. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178
2. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 1994, 10:1567-1574
3. Mariani SM, Matiba B, Bäumler C, Krammer PH: Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 1995, 25:2303-2307
4. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995, 14:1129-1135
5. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T cell suicide mediated by APO-1/(Fas/CD95). Nature 1995, 373: 438-441
6. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction meciates activation-induced apoptosis in T-cell hybridomas. Nature 1995, 373:441-444
7. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995, 373:444-448
8. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 1995, 377: 630-632
9. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192
10. Griffith TS, Ferguson TA: The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997, 18:240-244
11. Green DR, Ware CF: Fas-ligand: privilege and peril. Proc Natl Acad Sci USA 1997, 94:5986-5990
12. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Müller C, Tschopp J: Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues characterized by apoptotic cell turnover. J Cell Biol 1996, 133:335-343
13. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996, 184:1075-1082
14. Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini J, Tschopp J: Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 1996, 274:1363-1366
15. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat Med 1996, 2:1361-1366
16. O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: a molecular mechanism ot tumor immune privilege. Mol Med 1997, 3:294-300
17. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995, 16: 569-574
18. Nagata S, and Golstein P: The Fas death factor. Science 1995, 267:1449-1456
19. van-Parijs L, Abbas-AK: Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996, 8:355-361
20. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice is explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317
21. Takahashi T, Tanaka M, Brannan Cl, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mulation in the Fas ligand. Cell 1994, 76:969-976
22. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991, 9:243-269
23. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365
24. Mariani SM, Matiba B, Sparna T, Krammer PH: Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system. J Immunol Methods 1996, 193:63-70
25. Mariani SM, Matiba B, Armandola EA, Krammer PH: ICE-like proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 1997, 137:221-229
26. Möller P, Walczak H, Riedl S, Strater J, Krammer PH: Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia. Am J Pathol 1996, 149:9-13
27. Sträter J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Möller P: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997, 113:160-167
28. Mielke B, Möller P: Histomorphologic and immunophenotypic spectrum of primary gastrointestinal B-cell lymphomas. Int J Cancer 1991, 47:334-343
29. DeLellis RA: In situ hybridization techniques for the analysis of gene expression: applications in tumor pathology. Hum Pathol 1994, 25: 580-585
30. Villunger A, Egle A, Marschitz I, Kos M, Böck G, Ludwig H, Geley S, Kofler R, Greil R: Constitutive expression of Fas (APO-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood 1997, 90:12-20
31. Möller P, Henne C, Leithäuser F, Eichelmann A, Schmidt A, Brüderlein S, Dhein J, Krammer PH Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 1993, 81:2067-2075
32. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH, Möller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfimily, in normal and neoplastic cells. Lab Invest 1993, 69:415-429
33. Merville P, Dechanet J, Desmouliere A, Durand I, de Bouteiller O, Garrone P, Banchereau J, Liu YJ: Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 1996, 183:227-236
34. Tanaka M, Itai T, Adachi M, Nagata S: Downregulation of Fas ligand by shedding. Nat Med 1998, 4:31-36
35. Abreu-Martin MT, Vidrich A, Lynch DH, Targan SR: Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen. J Immunol 1995, 155:4147-4154
36. Strasser A, O'Connor L: Fas ligand: caught between Scylla and Charybdis. Nat Med 1998, 4:21-22